Project Indication Mechanism Preclinical IND Phase I Phase II
MAX-1 Solid Tumor IO
MAX-2 Solid Tumor IO
MAX-3 Auto Immune Targeted
MAX-4-A AML Targeted
MAX-4-S Solid Tumor Targeted
MAX-5 AML+CLL Targeted
MAX-6 Solid Tumor Targeted
MAX-7 Confidential Confidential Licensed Out
CONTACT US
我们非常开心能收到您的留言!
Please leave us a message,
we will reply to you as soon as possible, thank you!
© 2020 Maxinovel Pharmaceuticals / 再极医药科技有限公司
FIND US
研发中心: 上海市浦东新区高科中路1976号衡谷B幢5层
转化医学中心: 广州开发区科学大道181号商业广场A4栋10层1005室
Shanghai Address: 5th floor, Building B, No. 1976, Gaoke Middle Road, Pudong New District, Shanghai
Guanghzhou Address: Building A4-1005, 181 Science Blvd, Guangzhou Hitech Park, Guangdong Province
MAX-1
Indication: Solid Tumor Mechanism: IO
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-2
Indication: Solid Tumor Mechanism: IO
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-3
Indication: Auto Immune Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-4-A
Indication: AML Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-4-S
Indication: Solid Tumor Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-5
Indication: AML+CLL Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-6
Indication: Solid Tumor Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-7
Indication: Confidential Mechanism: Confidential
  • Preclinical
  • IND
  • Phase I
  • Phase ll
  • Licensed Out
© 2020 Maxinovel Pharmaceuticals / 再极医药科技有限公司
研发中心: 上海市浦东新区高科中路1976号衡谷B幢5层
转化医学中心: 广州开发区科学大道181号商业广场A4栋10层1005室
Shanghai Address: 5th floor, Building B, No. 1976, Gaoke Middle Road, Pudong New District, Shanghai
Guanghzhou Address: Building A4-1005, 181 Science Blvd, Guangzhou Hitech Park, Guangdong Province